RecruitingNot ApplicableNCT06606002

The Effectiveness of Group Schema Therapy in the Treatment of Borderline Symptoms in Adolescents

The Effectiveness of Group Schema Therapy Utilizing Video Material in the Treatment of Borderline Symptoms in Adolescents: A Randomized and Controlled Intervention Study


Sponsor

Turku University Hospital

Enrollment

64 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized and controlled trial is to assess the effectiveness of group schema therapy in the treatment of adolescents with borderline symptoms. The intervention utilizes self-recorded video material as an experiential method. The intervention comprises 30 group sessions and 8 individual sessions. Additionally, there are group sessions for the participants' parents. Participants in the control group receive treatment as usual.


Eligibility

Min Age: 15 YearsMax Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Group schema therapy and a behavioral approach called Treatment as Usual (TAU) for people with borderline personality disorder and borderline symptoms. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGroup schema therapy

Group schema therapy based on the model by Farrell and Shaw, which is complemented with separate group sessions for the participants' parents

BEHAVIORALTreatment as Usual (TAU)

TAU typically comprises visits at the outpatient clinic with variable frequency and content


Locations(1)

Turku University Hospital

Turku, Southwest Finland, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06606002


Related Trials